rxstat › Drug prices › Acetaminophen / Methocarbamol

Acetaminophen / Methocarbamol (Robaxacet, Robaxacet Extra Strength) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Also sold as: Robaxacet, Robaxacet Extra Strength, Extra Strength Muscle & Back Pain Relief, Muscle And Back Pain Relief Extra Strength

Acetaminophen / Methocarbamol 500 mg / 400 mg tablet costs about $0.19 per tablet on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. The brand (Robaxacet Extra Strength) lists at $0.66. It is not a covered benefit on the public plans we track; the price shown is a list price.

Acetaminophen / Methocarbamol has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABNS
500 mg / 400 mg Tabletper tablet$0.19not coveredbrand $0.66–
325 mg / 400 mg Tabletper tablet$0.33not coveredbrand $0.58–
Plan coverageNot coveredNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 6 products
  • Extra Strength Muscle & Back Pain Relief 500 mg / 400 mg Tablet · VTH
    DIN 02239141 · $0.19/tablet · Not covered
  • Muscle And Back Pain Relief 325 mg / 400 mg Tablet · WAM
    DIN 02237577 · $0.33/tablet · Not covered
  • Muscle And Back Pain Relief Extra Strength 500 mg / 400 mg Tablet · WAM
    DIN 02239742 · $0.36/tablet · Not covered
  • Robaxacet 325 mg / 400 mg Tablet · GKC
    DIN 02026805 · $0.58/tablet · Not covered
  • Extra Strength Tylenol Back Pain 500 mg / 400 mg Tablet · MCL
    DIN 02290510 · $0.63/tablet · Not covered
  • Robaxacet Extra Strength 500 mg / 400 mg Tablet · PDH
    DIN 02231176 · $0.66/tablet · Not covered
Nova Scotia: 2 products
  • Robaxacet 325 mg / 400 mg Tablet · WCH
    DIN 02026805 · no listed price · Not covered
  • Robaxacet Extra Strength 500 mg / 400 mg Tablet · WCH
    DIN 02231176 · no listed price · Not covered

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Acetaminophen / Methocarbamol. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Acetaminophen / Methocarbamol cost in Canada?

Acetaminophen / Methocarbamol 500 mg / 400 mg tablet costs about $0.19 per tablet on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. The brand (Robaxacet Extra Strength) lists at $0.66. It is not a covered benefit on the public plans we track; the price shown is a list price.

Is Acetaminophen / Methocarbamol covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Nova Scotia: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.